{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:32:18Z","timestamp":1762507938096,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,9,25]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>A 52-year-old man was referred to our dermatology clinic for a diagnosis of melanoma. At the time, his melanoma was excised he developed an annular, polycyclic, scaling eruption consistent with subacute cutaneous lupus erythematosus (SCLE). Skin biopsy and laboratory evaluation confirmed this diagnosis. The patient had been using pantoprazole for gastro-oesophageal reflux disease for the last 3\u2009years. The patient\u2019s melanoma was treated surgically, and his SCLE was treated with topical steroids and hydroxychloroquine. His SCLE cleared rapidly, his steroids and hydroxychloroquine were stopped and he remains free of SCLE off of treatment. The parallel course of the patient\u2019s SCLE and melanoma prompted consideration of SCLE as paraneoplastic to melanoma in this case. The clinical picture was complicated by the patient\u2019s use of a proton pump inhibitor, which are common causes of drug-induced SCLE. To our knowledge, this is the first reported case of possible paraneoplastic SCLE associated with melanoma.<\/jats:p>","DOI":"10.1136\/bcr-2019-230558","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T10:45:20Z","timestamp":1574937920000},"page":"e230558","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Subacute cutaneous lupus erythematosus with a possible paraneoplastic association with melanoma"],"prefix":"10.1136","volume":"12","author":[{"given":"Jesse","family":"Hirner","sequence":"first","affiliation":[{"name":"Dermatology, University of Missouri, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"2025082708175876000_12.11.e230558.1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1986.01660190043013"},{"key":"2025082708175876000_12.11.e230558.2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jbspin.2016.09.010","article-title":"First case of paraneoplastic subacute cutaneous lupus erythematosus associated with colon cancer","volume":"84","author":"Michel","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2025082708175876000_12.11.e230558.3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0190-9622(88)70188-7","article-title":"Subacute cutaneous lupus erythematosus associated with breast carcinoma","volume":"19","author":"Schewach-Millet","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"2025082708175876000_12.11.e230558.4","first-page":"E61","article-title":"Paraneoplastic cutaneous lupus secondary to esophageal squamous cell carcinoma","volume":"6","author":"Koritala","year":"2015","journal-title":"J Gastroinest Oncol"},{"key":"2025082708175876000_12.11.e230558.5","doi-asserted-by":"crossref","unstructured":"Mortazie M , Ramirez J , LaFond A . A case of paraneoplastic subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2016;AB78.","DOI":"10.1016\/j.jaad.2016.02.305"},{"key":"2025082708175876000_12.11.e230558.6","unstructured":"Fidahussein S , Sequeira H , Bois M , et al . Paraneoplastic subacute cutaneous lupus erythematosus as the first manifestation of small cell lung cancer. Am J Respir Crit Care Med 2014;189."},{"key":"2025082708175876000_12.11.e230558.7","doi-asserted-by":"publisher","DOI":"10.1007\/BF02207938"},{"key":"2025082708175876000_12.11.e230558.8","first-page":"25","article-title":"Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity","volume":"91","author":"Evans","year":"2013","journal-title":"Cutis"},{"key":"2025082708175876000_12.11.e230558.9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2230.2002.01102_4.x","article-title":"Association between subacute cutaneous lupus erythematosus and epidermoid carcinoma of the lung: a paraneoplastic phenomenon?","volume":"27","author":"Dawn","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"2025082708175876000_12.11.e230558.10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2230.2009.03240.x","article-title":"Paraneoplastic toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus","volume":"35","author":"Torchia","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"2025082708175876000_12.11.e230558.11","first-page":"581","article-title":"[Subacute cutaneous lupus erythematosus as a paraneoplastic syndrome]","volume":"61","author":"Kuhn","year":"1986","journal-title":"Z Hautkr"},{"key":"2025082708175876000_12.11.e230558.12","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/ajd.12251","article-title":"Paraneoplastic subacute cutaneous lupus erythematosus associated with cholangiocarcinoma","volume":"57","author":"Jenkins","year":"2016","journal-title":"Australas J Dermatol"},{"key":"2025082708175876000_12.11.e230558.13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1440-0960.2001.00491.x","article-title":"Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma","volume":"42","author":"Ho","year":"2001","journal-title":"Australas J Dermatol"},{"key":"2025082708175876000_12.11.e230558.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01900.x"},{"key":"2025082708175876000_12.11.e230558.15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000246090","article-title":"Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung","volume":"194","author":"Brenner","year":"1997","journal-title":"Dermatology"},{"key":"2025082708175876000_12.11.e230558.16","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1111\/j.1365-2230.2009.03549.x","article-title":"Subacute cutaneous lupus erythematosus associated with breast carcinoma","volume":"34","author":"Shaheen","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"2025082708175876000_12.11.e230558.17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.annder.2011.02.015","article-title":"[Subacute cutaneous lupus erythematosus and cancer: two cases and literature review]","volume":"138","author":"Gantzer","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"2025082708175876000_12.11.e230558.18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40801-016-0067-4","article-title":"Drug-Induced subacute cutaneous lupus erythematosus associated with proton pump inhibitors","volume":"3","author":"Aggarwal","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"2025082708175876000_12.11.e230558.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10969.x"},{"key":"2025082708175876000_12.11.e230558.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10397.x"},{"key":"2025082708175876000_12.11.e230558.21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjd.12699","article-title":"Proton pump inhibitor-induced subacute cutaneous lupus erythematosus","volume":"170","author":"Sandholdt","year":"2014","journal-title":"Br J Dermatol"},{"key":"2025082708175876000_12.11.e230558.22","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1111\/ajd.12681","article-title":"Subacute cutaneous lupus erythematosus induced by nivolumab","volume":"59","author":"Liu","year":"2018","journal-title":"Australas J Dermatol"},{"key":"2025082708175876000_12.11.e230558.23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/CMR.0000000000000536","article-title":"Subacute cutaneous lupus erythematosus induced by nivolumab: two case reports and a literature review","volume":"29","author":"Zitouni","year":"2019","journal-title":"Melanoma Res"},{"key":"2025082708175876000_12.11.e230558.24","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-213677","article-title":"Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1","volume":"78","author":"Michot","year":"2019","journal-title":"Ann Rheum Dis"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-230558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:18:07Z","timestamp":1756307887000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-230558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,28]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bcr-2019-230558"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-230558","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}